IP Verse

Use Of A Laminin For Differentiating Pluripotent Cells Into Hepatocyte Lineage Cells

PatentPatent Analysis

EP3059307

INSERM INSTITUT NATIONAL DE LA SANT ET DE LA RECHERCHE MDICALE
Application Number
EP15305265A
Filing Date
Feb 20, 2015
Status
Patent Maintained As Amended
Apr 2, 2022
Grant Date
May 4, 2022
External Links
Slate, Register, Google Patents
Similar Patents facing opposition
EP3911354B8
EP3066203B2
EP3995507B1

Bibliography

The patent EP3059307B2 was granted to Inserm Institut National DE LA Sant ET DE LA Recherche Mdicale on May 4, 2022 following the initial filing on Feb 20, 2015 under the application number EP15305265A . The current legal status of the patent is Patent Maintained As Amended.

AI Generated Summary New

Patent Family

Patent Family

Patent Oppositions filed by Competitors

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

CYTOCHROMAJul 17, 2019WITHDRAWN

Dossier Documents of the Patent

The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.

  • Date

    Description

  • Get instant alerts for new documents